Using virtual reality to reduce anxiety and pain during elective procedures in the cathlab
Virtual Reality as a Non-pharmacological Tool for Pain and Anxiety Relief During Elective Procedures in the Cathlab
This study is testing if using virtual reality can help reduce anxiety and pain for patients having elective procedures in the catheterization lab.
Quick facts
| Phase | Not applicable |
|---|---|
| Study type | Interventional |
| Enrollment | 64 (estimated) |
| Ages | 18 Years and up |
| Sex | All |
| Sponsor | Universitair Ziekenhuis Brussel Academic / other |
| Locations | 1 site (Brussels, Jette) |
| Trial ID | NCT06171620 on ClinicalTrials.gov |
What this trial studies
This study investigates the effectiveness of virtual reality (VR) as a non-pharmacological intervention to alleviate anxiety and pain in patients undergoing elective procedures in the catheterization laboratory. Patients scheduled for procedures will be randomly assigned to either a control group receiving standard care or an intervention group that will use a VR headset in addition to standard care. The primary outcomes will be measured using validated scales for anxiety, allowing for a comparative effectiveness analysis of the VR intervention in a clinical setting.
Who should consider this trial
Good fit: Ideal candidates are adults aged 18 and older who are undergoing elective procedures in the cathlab and are fluent in English, French, or Dutch.
Not a fit: Patients with cognitive impairments, severe hearing or visual impairments, or those who cannot comfortably wear the VR headset may not benefit from this study.
Why it matters
Potential benefit: If successful, this approach could significantly reduce anxiety and pain for patients undergoing elective procedures.
How similar studies have performed: Other studies have shown promising results using virtual reality for anxiety and pain management, suggesting this approach may be effective.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * Undergoing elective procedure in line with the following criteria in the cathlab of the UZB: limited feedback requirements from the patient to the physician, per-formed under local anaesthesia, risk estimated as normal i.e. haemodynamically stable patients (Stable vital signs such as heart rate and blood pressure) and no expected complications, electively planned and duration expected to be between 30 minutes and two hours. * Agreeing to participate via signed informed consent. * Being at least 18 years of age. * Being fluent in either English, French or Dutch language. Exclusion Criteria: * Ailments which would make wearing of the headset uncomfortable or impossible. * cognitive impairment such as dementia or delirium. * Severe hearing impairment, as this will limit the immersion. * Severe visual impairment not compensated by glasses, such as blindness.
Where this trial is running
Brussels, Jette
- Universitair Ziekenhuis Brussel — Brussels, Jette, Belgium (Recruiting)
Study contacts
- Principal investigator: Johan De Sutter, PHD, MD — University Ghent
- Study coordinator: Karen VandenBussche, PHD
- Email: Karen.VandenBussche@uzbrussel.be
- Phone: 02 477 60 09
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.